In breast cancer, leptin/STAT3 signalling is driven by obesity, which aggravates fatty acid oxidation (FAO) and reduces glycolysis in CD8+ T cells through the PD-L1 channel, which leads to inhibition of effector function and tumour growth [47]. The gene discussed is CD8A; the disease is breast cancer.